IBEX Limited

IBEX Limited (IBEX) Stock Overview

Explore IBEX Limited’s financial performance, market position, analyst ratings, and future outlook.

IBEXNASDAQ
TechnologyInformation Technology Services
$35.39
$0.76(2.19%)
U.S. Market opens in 50h 13m

IBEX Limited (IBEX)

Meyka AI Score

Z

Key Financials

Market Cap474.6M
P/E Ratio10.04
EPS (TTM)$3.55
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$31.89
3 Months$32.67
1 Year Target$39.94

IBEX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IBEX Limited (IBEX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.51, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $39.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.04 and a market capitalization of 474.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.17%
5-Day Change
7.67%
1-Month Change
16.03%
3-Month Change
19.08%
6-Month Change
-7.02%
Year-to-Date (YTD) Change
-7.31%
1-Year Change
16.99%
3-Year Change
70.64%
5-Year Change
54.54%
All-Time (Max) Change
129.81%

Contact Information

202 580 6200
1700 Pennsylvania Avenue NW, Washington, DC, 20006

Company Facts

360,000 Employees
IPO DateAug 7, 2020
CountryUS
Actively Trading

Frequently Asked Questions